Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.

Gynecologic oncology - 1 Mar 2022

Lin Douglas I, Fine Alexander, Danziger Natalie A, Huang Richard S P, Mata Douglas A, Decker Brennan, Killian Jonathan K, Ramkissoon Shakti H, Lechpammer Mirna, Janovitz Tyler, Ross Jeffrey S, Sokol Ethan S, Elvin Julia A

Abstract excerpt

OBJECTIVES: Endometrial serous carcinoma (EMSC) is an aggressive variant of uterine cancer with limited therapeutic options. We sought to define distinct clinicopathologic and genomic EMSC subgroups. METHODS: We retrospectively analyzed 2159 EMSC and 2346 endometrioid-type endometrial carcinomas (EEC) tissue specimens that had undergone comprehensive genomic profiling (CGP) via the FoundationOne CDx assay during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Class I Phosphatidylinositol 3-Kinases

Share to Cystadenocarcinoma, Serous

Share to Endometrial Neoplasms

Share to Microsatellite Instability

Share to Mutation

Source

Identifiers

PMID: 34998597
DOI: 10.1016/j.ygyno.2021.12.030

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.PMID 34998597Read ↗

Whole-genome sequencing-based characterization of endometrial serous carcinoma.Semantic proximity Read ↗

Molecular classification of ovarian high-grade serous/endometrioid carcinomas through multi-omics analysis: JGOG3025-TR2 study.Semantic proximity Read ↗

A multiomics comparison between endometrial cancer and serous ovarian cancerSemantic proximity Read ↗

The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunitiesSemantic proximity Read ↗

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancerSemantic proximity Read ↗

Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in Uterine Serous Carcinoma.Semantic proximity Read ↗

Molecular Classification of Endometrial Carcinomas: Review and Recent UpdatesSemantic proximity Read ↗

The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunitiesSemantic proximity Read ↗

Molecular Genetics of Endometrial CarcinomaSemantic proximity Read ↗

Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparibSemantic proximity Read ↗

Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort StudySemantic proximity Read ↗

Patient-derived xenograft models capture genomic heterogeneity in endometrial cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.